Tag: triart

Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.

Os peptídeos terapêuticos são uma classe emergente de insumos farmacêuticos ativos que, juntamente com outras classes de bioprodutos, vêm despertando grande interesse devido às suas vantagens únicas.

El primer péptido estudiado en este campo fue la insulina, una cadena de 51 aminoácidos que fue aislada originalmente en 1921 por Frederick Banting y Charles Best y que posteriormente se convirtió en el primer péptido disponible comercialmente (1923). Actualmente, existe una extensa lista de péptidos disponibles comercialmente en el mercado, incluidos los conocidos análogos de GLP-1, como liraglutida, semaglutida y tirzepatida.

What’s the big deal about YMC-Triart? Simple. Instead of ordinary spherical silica as the base particle in the stationary phase, YMC-Triart phases start with a novel hybrid particle of alternate layers of inorganic and organic silane material. It is on

There is a lot of interest in HILIC (hydrophilic interaction liquid chromatography), particularly among LC/MS users.  Mobile phases used in HILIC separations are generally “LC/MS friendly.” YMC-Triart Diol-HILIC begins with an organic/inorganic hybrid base particle with excellent durability and usability

YMC-Triart is a novel organic/inorganic hybrid silica particle. Triart products display superior physical (mechanical strength and temperature) and chemical (pH) durability and chromatographic performance when compared to conventional silica and other hybrid silica materials. YMC’s growing line of hybrid materials